Credentials

The following are selected published patent and patent applications pointing out the skills and experience of management members.

  • Topical antifungal compositions., WO2017062761(A1), April 13, 2017.
  • Energy Patch, US 2016256407(A1), September 08, 2016.
  • Compositions and methods for transdermal delivery of hormones and other medicinal agents US Patent US 9,579,296 February 28, 2017.
  • Sensitization composition and Method of use, MA37459, June 30, 2016.
  • Compositions and methods for transdermal delivery of hormones and other medicinal agents US Patent Application # 20160051487, February 25, 2016.
  • Highly permeating terbinafine formulation, US Patent Application 2015342871 (A1) December 3, 2015
  • Sprayable analgesic composition US Patent Application 2015/058927, November 4, 2015.
  • Foamable formulation, US Patent #9,107,823, (2015).
  • Foamable formulation, US Patent Application 2015297518 (A1) October 22, 2015
  • Highly permeating terbinafine formulation, US Patent # 9,084,754 (2015).
  • Compositions and methods for transdermal delivery of hormones and other medicinal agents US Patent # 9,144,553 (2015).
  • Energy patch WO2015054608 (A1) April 16, 2015.
  • Sensitization Composition and method of use US Patent application # 20150110904 (2015).
  • Topical ketoprofen composition US Patent # 8,822,537, (2014).
  • Topical Ketoprofen composition, US patent Application # 20140088195 March 27, 2014
  • Wound dressing comprising chlorite, US Patent Application # 20130316020 November 28, 2013.
  • Topical Ibuprofen formulations. US Patent # 8,470,886 (2013).
  • Foamable formulation , US Patent Application 20130243701 September 19, 2013
  • Foamable Compositions of stabilized chlorite, US Patent Application # 20130136805 May 30, 2013.
  • Wound dressings comprising chlorite. US Provisional patent application 61/441,016 (Feb 9, 2011). PCT Patent application WO/2012/106822 Aug 16, 2012
  • Foamable compositions of stabilized chlorite. US Provisional patent application 61/373,467 (Aug 13, 2010). PCT Patent application WO/2012/019288 Feb 16, 2012
  • Pharmaceutical formulations and methods of use. US Provisional Patent application 61/237,252 (Aug 26, 2009). PCT Patent Application WO/2011/028629 Mar 10, 2011
  • Foamable formulation. US Provisional patent application 61/312,629 (Mar 10, 2010). PCT Patent application WO/2011/112875 (Sep 15, 2011) 2011.
  • Topical Etoricoxib formulation. US Provisional patent application 61/349,712 (May 28, 2010). PCT Patent application WO/2011/149645 (Dec 1, 2011) 2011.
  • Highly permeating Terbinafine formulation for treating onycomycosis. US Provisional patent application 61/289,967 (Dec 23, 2009). PCT Patent application WO/2011/079234 (Jun 30, 2011) 2011.
  • Topical eutectic-based formulations. US Provisional patent application 61/230,473 (July 31, 2009). PCT Patent application WO/2011/014850 (Feb 3, 2011) 2011.
  • Topical formulations. US Provisional patent application 61/247,222 (Sept 30, 2009). PCT Patent application WO/2011/041609 (Apr 7, 2011) 2011.
  • Topical formulation comprising Etoricoxib and a zwitterionic surfactant. US Provisional patent application 61/250,452 (Oct 09, 2009). PCT Patent application WO/2011/044540 (Apr 14, 2011) 2011.
  • Topical Etoricoxib formulation comprising an eutectic mixture of permeation enhancers. US Provisional patent application 61/260,351 (Nov 11, 2009). PCT Patent application WO/2011/060195 (May 19, 2011) 2011.
  • Topical Ibuprofen formulations. US Provisional patent application 61/264,724 (Nov 27, 2009). PCT Patent application WO/2011/063531 (June 3, 2011) 2011.
  • Formulations for the treatment of acute Herpes Zoster pain. PCT Patent application PCT/US 2009/063414 (Nov 5, 2009) 2009.
  • Prostaglandin compositions and methods of treatment for male erectile dysfunction, US Patent # 7,105,571 (2006).
  • Peroxide compounds for the prevention and treatment of sexual dysfunction in humans (US Patent Application 20050276865).
  • Topical treatment and prevention of human papilloma virus (HPV) infection (US Patent Application 20050272700).
  • Method for the longterm stabilization of labile compounds at room temperature in pharmaceutical preparations containing water (US Patent Application 20050255161).
  • Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents (US Patent Application 20050113274).
  • Compositions and methods for amelioration of human female sexual dysfunction (US Patent Application 20050004226).
  • Compositions and methods for amelioration of human female sexual dysfunction, US Patent #6,825,234 (2004).
  • Prostaglandin compositions and methods of treatment for male erectile dysfunction, US Patent #6,693,135 (2004).
  • Methods of treatment of male erectile dysfunction US Patent Application (20040110843).
  • Treatment of erectile dysfunction US Patent Application (20030220292).
  • Compositions and methods for amelioration of human female sexual dysfunction, US Patent #6,486,207 (2002).
  • Topical compositions containing prostaglandin E1, US Patent #6,414,028 (2002).
  • Prostaglandin compositions and methods of treatment for male erectile dysfunction, US Patent #6,323,241 (2001).
  • Crystalline salts of dodecyl 2-(N, N-dimethylamino) propionate, US Patent #6,118,020 (2000).
  • Topical compositions for NSAI drug delivery, US Patent #6,083,996 (2000).
  • Topical compositions for prostaglandin E1 delivery, US Patent #6,046,244 (2000).
  • Absorption enhancers for topical pharmaceutical formulations, ES2233933 (T3) ― 2005-06-16. WO9509590 (A1) ― 1995-04-13